CancerVolume 10, Issue 2 p. 231-238 ArticleFree Access Biological effects of the phosphoramides in patients with advanced cancer Edward W. Humphrey M.D., Edward W. Humphrey M.D. Departments of Surgery of the University of Minnesota, the Veterans Administration Hospital, and the Minneapolis General Hospital, Minneapolis, MinnesotaSearch for more papers by this authorClaude R. Hitchcock M.D., PH.D., Claude R. Hitchcock M.D., PH.D. Departments of Surgery of the University of Minnesota, the Veterans Administration Hospital, and the Minneapolis General Hospital, Minneapolis, MinnesotaSearch for more papers by this author Edward W. Humphrey M.D., Edward W. Humphrey M.D. Departments of Surgery of the University of Minnesota, the Veterans Administration Hospital, and the Minneapolis General Hospital, Minneapolis, MinnesotaSearch for more papers by this authorClaude R. Hitchcock M.D., PH.D., Claude R. Hitchcock M.D., PH.D. Departments of Surgery of the University of Minnesota, the Veterans Administration Hospital, and the Minneapolis General Hospital, Minneapolis, MinnesotaSearch for more papers by this author First published: March/April 1957 https://doi.org/10.1002/1097-0142(195703/04)10:2<231::AID-CNCR2820100204>3.0.CO;2-6Citations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Bateman, J. C., and Winship, T.: Palliation of ovarian carcinoma with phosphoramide drugs. Surg., Gynec. & Obst. 102: 347– 354, 1956. 2 Davidson, J. D., and Freeman, B. B.: The effects of antitumor drugs upon P32 incorporation into nucleic acids of mouse tumors. Cancer Research 15: 31– 37, 1955. 3 Farber, S.; Appleton, R.; Downing, V.; Heald, F.; King, J., and Toch, R.: Clinical studies on the carcinolytic action of triethylenephosphoramide. Cancer 6: 135– 141, 1953. 4 Feigelson, P., and Davidson, J.: The in vitro inhibition of xanthine dehydrogenase by 8-azoguanine. Cancer Research 16: 352– 356, 1956. 5 Field, J. B.: Triethylenephosphoramide (TEPA) in malignant melanoma. [Abstr.] Federation Proc. 13: 206, 1954. 6 Shay, H., and Sun, D. C. H.: Clinical studies of triethylenethiophosphoramide in the treatment of inoperable cancer. Cancer 8: 498– 511, 1955. 7 Skipper, H. E., and Mitchell, J. H., Jr.: Effect of roentgen-ray radiation on the biosynthesis of nucleic acids and nucleic acid purines. Cancer 4: 363– 366, 1951. 8 Vermund, H.; Barnum, C. P.; Huseby, R. A., and Stenstrom, K. W.: The effect of roentgen radiation on the incorporation of radiophosphorus into nucleic acids and other constituents of mouse mammary carcinoma. Cancer Research 13: 633– 638, 1953. 9 Zarafonetis, C. J. D.; Shay, H., and Sun, D. C. H.: Triethylenethiophosphoramide in the treatment of chronic leukemia. Cancer 8: 512– 522, 1955. Citing Literature Volume10, Issue2March/April 1957Pages 231-238 ReferencesRelatedInformation